alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

          In connection  with the Annual  Report on Form 10-KSB of  SheerVision,
Inc.  (the  "Company")  for the fiscal year ended August 31, 2006 filed with the
Securities and Exchange Commission (the "Report"),  I, Suzanne Lewsadder,  Chief
Executive Officer of the Company,  certify,  pursuant to 18 U.S.C. Section 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully  complies  with the  requirements  of Section  13(a) of the
Securities Exchange Act of 1934; and

(2) The  information  contained in the Report fairly  presents,  in all material
respects,  the consolidated  financial  condition of the Company as of the dates
presented and consolidated  results of operations of the Company for the periods
presented.

Dated: November 28, 2006


By:  /s/ Suzanne Lewsadder
     ------------------------------
     Suzanne Lewsadder
     Chief Executive Officer



This  certification  has been  furnished  solely  pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002.

A signed  original of this  written  statement  required by Section 906 has been
provided to  SheerVision,  Inc.  and will be retained by  SheerVision,  Inc. and
furnished to the Securities and Exchange Commission or its staff upon request.
<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM AUDITED
FINANCIAL STATEMENTS FOR THE YEAR ENDED DECEMBER 31, 1999 AND IS QUALIFIED IN
ITS ENTIRETY BY REFERENCE TO SUCH ONE VOICE TECHNOLOGIES, INC. 10-KSB.
</LEGEND>

<S>                             <C>
<PERIOD-TYPE>                   YEAR
<FISCAL-YEAR-END>                          DEC-31-1999
<PERIOD-START>                             JAN-01-1999
<PERIOD-END>                               DEC-31-1999
<CASH>                                       1,104,485
<SECURITIES>                                         0
<RECEIVABLES>                                        0
<ALLOWANCES>                                         0
<INVENTORY>                                          0
<CURRENT-ASSETS>                             1,104,485
<PP&E>                                         153,962
<DEPRECIATION>                                (12,922)
<TOTAL-ASSETS>                               1,801,057
<CURRENT-LIABILITIES>                          621,394
<BONDS>                                              0
<PREFERRED-MANDATORY>                                0
<PREFERRED>                                          0
<COMMON>                                        11,370
<OTHER-SE>                                   1,168,293
<TOTAL-LIABILITY-AND-EQUITY>                 1,801,057
<SALES>                                         25,423
<TOTAL-REVENUES>                                25,423
<CGS>                                            2,790
<TOTAL-COSTS>                                    2,790
<OTHER-EXPENSES>                             1,804,848
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                   0
<INCOME-PRETAX>                            (1,782,215)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                        (1,782,215)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                               (1,782,215)
<EPS-BASIC>                                    (.15)
<EPS-DILUTED>                                    (.15)


</TABLE>
EXHIBIT 12.1

CERTIFICATION

I,
Takis Arapoglou, certify that:

Date: July 14, 2005

/s/TAKIS ARAPOGLOUTakis Arapoglou
Chairman and Chief Executive Officer


---



CERTIFICATION

I,
Ioannis Pechlivanidis, certify that:

Date: July 14, 2005

/s/IOANNIS PECHLIVANIDISIoannis Pechlivanidis
Deputy Chief Executive Officer


---



CERTIFICATION

I,
Anthimos Thomopoulos, certify that:

Date: July 14, 2005

/s/ANTHIMOS THOMOPOULOSAnthimos Thomopoulos
Chief Financial Officer and
Chief Operations Officer


---



QuickLinks
exv10wb






Exhibit (10)b.




AMENDMENT NO. 4

TO TRADEMARK LICENSE AGREEMENT

(U.S. Dockers)




     This Amendment No. 4 dated May 15, 2009 amends that certain Trademark License Agreement dated
August 9, 2000 (the “Agreement”), as amended, by and between LEVI STRAUSS & CO., a Delaware
corporation, (“LS&CO.”) and GENESCO INC. (“Licensee”), a Tennessee corporation located at 1415
Murfreesboro Road, Nashville, TN 37217.



     Pursuant to Section 24.4, Entire Agreement; Modifications, the Parties amend the
Agreement as set forth below:




	1.	 	Section 2.1, Term shall be amended to reflect that the Agreement is extended for an
additional three (3) Annual Periods commencing on January 1, 2010 and ending on December 31,
2012.
	 
	2.	 	Section 2.2, Renewal Term is hereby deleted in its entirety and substituted with the
following:
	 
	 	 	“Section 2.2. Expiration or Renewal. LS&CO. and Licensee agree that the Term of
this Agreement shall expire as of December 31, 2012.”
	 
	3.	 	Section 3.1, Guaranteed Minimum Royalty shall be amended to add the following
Guaranteed Minimum Royalty payments to the Term:





	 	 	 
	Annual Period	 	Guaranteed Minimum Royalty
	 

	 	[                         ]*







	4.	 	Section 24, Notices shall be amended by removing the Levi Strauss & Co. notices
addresses and replacing them with the following:




If to LS&CO.:



David Galpin

Vice President, DockersÒ Licensing

Levi Strauss & Co.

1155 Battery Street

San Francisco, CA 94111






 




			
	*	 	CONFIDENTIAL INFORMATION HAS BEEN OMITTED AND FILED
SEPARATELY WITH THE COMMISSION.















 




Telephone: (415) 501-6000

Facsimile: (415) 501-1484



With copy to:



Hilary A. Dessouky

Associate General Counsel

Levi Strauss & Co.

1155 Battery Street

San Francisco, CA 94111

Telephone: (415) 501-6000

Facsimile: (415) 501-7650





	5.	 	Except as set forth above, all other terms and conditions contained in the Agreement shall
remain in full force and effect. This Amendment and the Agreement (a) are complete, (b)
constitute the entire understanding between the Parties with respect to the subject matter
hereof, and (c) supersede all prior agreements, whether oral or written.





     IN WITNESS WHEREOF, the Parties have executed this Amendment No. 4 by their respective
officers hereunto duly authorized as of the day and year first written above.



	 	 	 	 	 	 	 	 	 
	LEVI STRAUSS & CO.	 	GENESCO, INC.	 	 
	 
	 	 	 	 	 	 	 	 
	By:

	 	/s/: Jim Calhoun
 

Jim Calhoun
	 	By:

Name:
	 	/s/: Jonathan Caplan
 

Jonathan Caplan
	 	 
	 

	 	President, DockersÒ
	 	Title:
	 	CEO — Brand Group
NO. 12-09-00121-CR

IN THE COURT OF APPEALS

TWELFTH COURT OF APPEALS DISTRICT

TYLER, TEXAS

§

IN RE: DAVID GEORGE BAUGH,

RELATOR § ORIGINAL PROCEEDING

§

MEMORANDUM OPINION

PER CURIAM

David George Baugh seeks release from his confinement in the Cherokee County Jail. He

complains that the trial court has refused to release him on a personal recognizance bond pending

trial despite his proven indigence.

Baugh has designated his request for relief as an “Emergency Petition for Writ of

Mandamus.” However, it is the substance of a document that governs, and not the title. Ex parte

Caldwell, 58 S.W.3d 127, 130 (Tex. Crim. App. 2000). Baugh is, in effect, seeking pretrial habeas

relief. Therefore, we construe the filed document as an application for a pretrial writ of habeas

corpus. 

The Texas Government Code provides as follows:

Concurrently with the supreme court, the court of appeals of a court of appeals district in which a

person is restrained in his liberty, or a justice of the court of appeals, may issue a writ of habeas corpus

when it appears that the restraint of liberty is by virtue of an order, process, or commitment issued by

a court or judge because of the violation of an order, judgment, or decree previously made, rendered,

or entered by the court or judge in a civil case. Pending the hearing of an application for a writ of

habeas corpus, the court of appeals or a justice of the court of appeals may admit to bail a person to

whom the writ of habeas corpus may be granted.

TEX. GOV'T CODE ANN. § 22.221(d) (Vernon 2004). Thus, the original jurisdiction of courts of
2

appeals to issue a writ of habeas corpus is limited to those cases in which a person's liberty is

restrained because the person has violated an order, judgment, or decree entered in a civil case. Id.

Consequently, courts of appeals do not have original habeas corpus jurisdiction in criminal law

matters. Dodson v. State, 988 S.W.2d 833, 835 (Tex. App.–San Antonio 1999, no pet.); Ex parte

Hawkins, 885 S.W.2d 586, 588 (Tex. App.–El Paso 1994, no pet.). In such matters, their jurisdiction

is appellate only. Dodson, 988 S.W.2d at 835. Because Baugh seeks habeas relief in an original

proceeding, we are without jurisdiction to consider his application. Accordingly, we dismiss Baugh's

application for want of jurisdiction.

Opinion delivered June 17, 2009.

Panel consisted of Worthen, C.J., Griffith, J., and Hoyle, J.

(DO NOT PUBLISH)
Case 1:07-cv-03475-LAP Document 7-5 Filed 07/23/2007 Page 1 of 1
Exhibit 21.01

Exhibit 21.01List of Subsidiaries

Name of Subsidiary

Jurisdiction of
Incorporation or
OrganizationDomestic:American Home Buyers Alliance, Inc.

WyomingCoral Aviation, Inc.

DelawareEduTrades, Inc.

NevadaMortgage Reduction System EquityCorp.

FloridaSCB Building, LLC

FloridaTranquility Bay of Southwest FL, LLC

FloridaWhitney Consulting Services, Inc.

WyomingWhitney Education Group, Inc.

FloridaWealth Intelligence Academy, Inc.

FloridaWhitney Leadership Group, Inc.

FloridaInternational:Whitney Australia PTY LTD

AustraliaWhitney Canada, Inc.

CanadaWhitney Development Limited

United KingdomWhitney Education Deutschland GmbH

GermanyWhitney International Limited

United KingdomWhitney International (Singapore) PTE. LTD

SingaporeWhitney UK Limited

United Kingdom


---



QuickLinks
Document

Exhibit 10.41
EXAGEN INC.
February 21, 2020
Debra Zack, MD Ph.D.
Dear Dr. Zack,
I am pleased to confirm our offer for you to join Exagen Inc. as Chief Medical Officer with a start date of 3/24/2020. This offer is contingent upon the successful completion of a pre-employment background check and proof of work eligibility.  This is an exempt position and will report to Ron Rocca. We are offering you a bi-weekly salary of $14,615.38 ($380,000.00 annualized).
You are eligible for achievement incentive compensation which will be contingent on you meeting certain performance goals. Your annual incentive compensation will be worth 45% of your annual salary and will be pro-rated in the first year to start date. In addition, you will receive 100,000 options to purchase the company's common stock contingent upon the approval of the Exagen Board of Directors, the timing of which will also be subject to the Board's discretion.
You are eligible to participate in the Exagen benefits program, a summary of which you will receive under separate cover. You will accrue 3 weeks (or 120 hours) of paid time off a year in addition to the ten holidays currently recognized by Exagen.
Exagen currently has a safe harbor 40l(k) plan and contributes an amount equal to 3% of your annual income into your 40l(k). There is no vesting period in the 40l(k). You must be employed by Exagen for 3 months before becoming eligible to participate in the 40l(k).
Employment at Will:  This letter is intended to communicate certain terms and conditions of employment with Exagen Inc. but is not intended to be and should not be considered an employment contract. Your employment is not for a specific duration and may be terminated by you or Exagen Inc. at any time, for any reason or for no reason whatsoever, with or without notice and with or without cause unless otherwise specified by law. Your employment is "at will." The "at will" status of your employment may not be altered except by a separate written contract signed by the Chief Financial Officer of Exagen Inc. No one other than the Chief Financial Officer has the authority to enter into an employment contract with you.  
I look forward to working with you as a member of the Exagen team. We are excited about the contributions you will make to the success of our company. If you have any further questions, please do not hesitate to contact me.
Sincerely,
									
			I Accept the Offer Stated Above
	 /s/ Kamal Adawi		 /s/ Debra Zack
	Kamal Adawi		Debra Zack, MD Ph.D.
	Chief Financial Officer
#### NEWMAN v. NEWMAN

No. 355 PC.

Case below: 53 N.C. App. 630.

Petition by defendant for discretionary review under G.S. 7A-31 denied 12 January 1982.
#### TAYLOR v. BAILEY

No. 6

Case below: 49 NC App 216

Motions of plaintiff and defendant to dismiss appeal allowed 13 January 1981.
Case 1:07-cv-02262-WHP Document 19-4 Filed 04/01/2008 Page 1 of 3
Case 1:07-cv-02262-WHP Document 19-4 Filed 04/01/2008 Page 2 of 3
Case 1:07-cv-02262-WHP Document 19-4 Filed 04/01/2008 Page 3 of 3
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 1 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 2 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 3 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 4 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 5 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 6 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 7 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 8 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 9 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 10 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 11 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 12 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 13 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 14 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 15 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 16 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 17 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 18 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 19 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 20 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 21 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 22 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 23 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 24 of 25
Case 1:07-cv-03496-WHP Document 16-42 Filed 06/20/2007 Page 25 of 25
[DO NOT PUBLISH]

IN THE UNITED STATES COURT OF APPEALS

FOR THE ELEVENTH CIRCUIT

________________________

No. 15-15000

________________________

D.C. Docket No. 1:14-cv-24594-MGC

In Re: MRS. PATRICIA DOUGHERTY,

BRIAN A. SIDMAN, 

an individual, 

 Plaintiff-Counter

 Defendant-Appellee,

 versus

JOSEPH P. DOUGHERTY, 

11106 Crescent Bay Blvd.

Clermont, FL 34711

352-988-3507

an individual, 

 Defendant-Third Party

 Plaintiff-Counter 

 Claimant-Appellant,

Case: 15-15000 Date Filed: 10/03/2017 Page: 1 of 3 
2

DOMAINS BY PROXY LLC,

a Delaware corporation, et al.,

 Defendants,

LOUIS ROGERS

10900 Nuckols Road

Suite 200

Glen Allen, VA 23060

804-290-7900, et al.,

 Third Party Defendants.

________________________

Appeal from the United States District Court

for the Southern District of Florida

________________________

(October 3, 2017)

Before HULL, JORDAN, and BOGGS,* Circuit Judges.

PER CURIAM: 

After careful review of the record and the parties’ briefs, and with the 

benefit of oral argument, this Court finds no reversible error in the district court’s 

October 6, 2015 order denying Appellant Joseph P. Dougherty’s request for costs 

and attorney’s fees or in the district court’s April 19, 2016 order denying Appellant 

 *

Honorable Danny J. Boggs, United States Circuit Judge for the Sixth Circuit, sitting by 

designation.

Case: 15-15000 Date Filed: 10/03/2017 Page: 2 of 3 
3

Dougherty’s motion for reconsideration. Accordingly, we affirm both of the 

district court’s orders.

AFFIRMED.

Case: 15-15000 Date Filed: 10/03/2017 Page: 3 of 3
# STATE OF LOUISIANA



# COURTOFAPPEAL, FIRSTCIRCUIT STATE OF LOUISIANA VERSUS VICTOR COVINGTON NO. 

### 2022 Kw 0542 JULY 18, 2022 In Re: Victor Covington, 

## applying for supervisory writs, 20th

Judicial District Court, Parish of East Feliciana, No. 

### 96 -CR - 1253. BEFORE: HOLDRIDGE, PENZATO, AND LANIER, JJ.

WRIT DENIED. GH AHP WIL



### COURT OF APPEAL, FIRST CIRCUIT 

# 01•C04 DEPUTY CLERK OF COURT

FOR THE COURT
# C_2011068EN.01000601.xml

| 3.3.2011 | EN | Official Journal of the European Union | C 68/6 |
| --- | --- | --- | --- |

3.3.2011

EN

Official Journal of the European Union

C 68/6

---

Notice of the expiry of certain countervailing measures

2011/C 68/05

Further to the publication of a notice of impending expiry (1) following which no request for a review was lodged, the Commission gives notice that the countervailing measure mentioned below will shortly expire.

1

This notice is published in accordance with Article 18(4) of Council Regulation (EC) No 597/2009 of 11 June 2009 on protection against subsidised imports from countries not members of the European Community (2).

2

| Product | Country of origin or exportation | Measures | Reference | Date of expiry |
| --- | --- | --- | --- | --- |
| Polyethylene terephthalate (PET) film | India | Countervailing duty | Council Regulation (EC) No 367/2006 (OJ L 68, 8.3.2006, p. 15) as last amended by Council Implementing Regulation (EU) No 806/2010 (OJ L 242, 15.9.2010, p. 6) | 9.3.2011 |

Product

Country of origin or exportation

Measures

Reference

Date of expiry

Polyethylene terephthalate (PET) film

India

Countervailing duty

Council Regulation (EC) No 367/2006 (OJ L 68, 8.3.2006, p. 15) as last amended by Council Implementing Regulation (EU) No 806/2010 (OJ L 242, 15.9.2010, p. 6)

9.3.2011

---

(1)  OJ C 294, 29.10.2010, p. 9.

1

(2)  OJ L 188, 18.7.2009, p. 93.

2

---
EXHIBIT
(32)




CERTIFICATION
OF EXECUTIVE OFFICERS*




Pursuant
to 18 U.S.C. section 1350, each of the undersigned officers of La-Z-Boy
Incorporated (the “Company”) hereby certifies, to such officer’s knowledge, that
the Company’s Quarterly Report on Form 10-Q for the period ended January 24,
2009 (the “Report”) fully complies with the requirements of section 13(a) or
15(d), as applicable, of the Securities Exchange Act of 1934 and the information
contained in the Report fairly presents, in all material respects, the financial
condition and results of operations of the Company.




/s/ Kurt L.
      DarrowKurt
      L. DarrowPresident
      and Chief Executive OfficerFebruary
      18, 2009/s/ Louis M. Riccio, Jr.Louis
      M. Riccio, Jr.Senior
      Vice President and Chief Financial OfficerFebruary
      18, 2009




*The
foregoing certification is being furnished solely pursuant to 18 U.S.C. section
1350 and is not being filed as part of the Report or as a separate disclosure
document.
Exhibit 10.1

Certification of the Principal Executive Officer
Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Annual Report of Pemex Finance Limited (the "Company") on Form 20-F for the year ended December 31, 2002 as filed
with the Securities and Exchange Commission on the date hereof (the "Report"), I, Ricardo Fernández Delgado, President of the Company, certify, pursuant to 18 U.S.C. § 1350,
as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | /s/RICARDO FERNÁNDEZ DELGADORicardo Fernández Delgado
President
Dated: June 27, 2003
| | ------------------------------------------------------------------------------------

A
signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.

---

QuickLinks
EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of K-V Pharmaceutical Company (the
Company) on Form 10-Q for the quarter ended September 30, 2008, as filed with the Securities and Exchange Commission on the date hereof (the Report), I, Thomas S. McHugh, Interim Chief Financial Officer, Interim
Treasurer, Chief Accounting Officer, Vice President of Finance and Corporate Controller of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:



| | (1) | The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | --- | ---------------------------------------------------------------------------------------------------------------------



| | (2) | The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| | --- | ----------------------------------------------------------------------------------------------------------------------------------------------------



|                     |  |  |  |                                                                                                                                                                               
|-------------------- |  |  |  | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|Date: March 25, 2010 |  |  |  | /s/    Thomas S.
McHugh                                                                                                                                                       
|                     |  |  |  | Thomas S. McHugh Interim Chief Financial Officer, Interim Treasurer, ChiefAccounting Officer, Vice President of Finance and Corporate
Controller (Principal Financial Officer)

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the
signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission
or its staff upon request.

The foregoing certification is being furnished to the Securities and Exchange Commission as our exhibit to the
Quarterly Report on Form 10-Q and shall not be deemed to be considered filed as part of the Quarterly Report Form 10-Q.
Case 1:07-cv-03580-DLC Document 4 Filed 05/16/2007 Page 1 of 1
#### STATE v. McGRAW

No. 44PA82.

Case below: 55 N.C. App. 481.

Petition by Attorney General for discretionary review under G.S. 7A-31 allowed 30 March 1982.
IN THE SUPREME COURT OF THE STATE OF MONTANA

No. 24-0067

CITY OF WHITEFISH,

Plaintiff and Appellee,

v.

AARON JOSEPH BROUGHTON,

Defendant and Appellant.

ORDER

Upon consideration of Appellant’s motion for extension of time, 

and good cause appearing,

IT IS HEREBY ORDERED that Appellant is granted an extension 

of time to and including June 10, 2024, within which to prepare, file, 

and serve Appellant’s opening brief on appeal.

Electronically signed by:

Mike McGrath

Chief Justice, Montana Supreme Court

May 1 2024

05/01/2024

Case Number: DA 24-0067